Tokyo-based I’rom Group, renowned for its pioneering advancements in medical technology, is set to revolutionize the field of regenerative medicine with a groundbreaking project that combines non-fungible tokens (NFTs) and blockchain technology.
By storing valuable iPS cell data on a decentralized ledger, I’rom Group aims to secure the future of regenerative medicine while offering unparalleled transparency and accessibility.
I’rom Group announced the signing of a strategic cooperation deal with the WorldScan Project (WSP) on August 7. WSP is a Tokyo and New York-based provider of drone, web3 infrastructure, and NFT services. As a result, both businesses will utilize NFT to create the Medical Web 3.
I’rom and WorldScan Project have launched the “iCELL BANK Project“ as a first step. In 2024, the project is expected to begin providing services.
The “iCELL BANK Project” will create client iPS cells using the “CytoTune-iPS ” iPS cell manufacturing kit from the I’rom Group.
The customer can use their own iPS cells to make differentiated cells from the iPS cells as needed and use them for regenerative medicine and custom-made cosmetics by preserving their iPS cells.
Since it takes time to create iPS cells, the goal of this study is to store them beforehand so that they can be employed right away when necessary.
I’rom Group’s iPS Cell Storage: How can Blockchain Technology help customers in this project
I’rom Group’s bold initiative to combine regenerative medicine with blockchain technology aims to leverage the transformative power of both realms to benefit customers in unprecedented ways.
The key focus of this project lies in the management and storage of induced pluripotent stem (iPS) cell data on the blockchain.
iPS cells are derived from adult cells that have been reprogrammed to possess the ability to differentiate into various cell types found in the human body.
With their immense potential for tissue regeneration and disease modeling, iPS cells have emerged as a cornerstone of regenerative medicine.
The utilization of blockchain technology in this aspect offers several compelling advantages. Firstly, the immutable nature of the blockchain ensures the secure and permanent storage of iPS cell data.
This eliminates concerns regarding data loss, tampering, or unauthorized access, crucial factors in maintaining the integrity and traceability of these valuable cellular resources.
Secondly, the decentralized nature of blockchain technology creates a transparent and auditable framework that guarantees trust among stakeholders.
Researchers, clinicians, and patients will have real-time access to the stored iPS cell data, enabling seamless collaboration, data sharing, and verification. This level of transparency fosters a more efficient and inclusive research ecosystem, ultimately accelerating advancements in regenerative medicine.
I’rom to introduce iPS NFTs for ownership
Customers who produce iPS cells will receive a “iPS NFT,” of which they will take ownership. The owner of “iPS NFT” has access to data on iPS cells that are kept on the blockchain and is free to use it.
Furthermore, the implementation of non-fungible tokens (NFTs) within this project introduces an additional layer of value and ownership representation.
Each iPS cell dataset can be uniquely tokenized as an NFT, creating a digital certificate of authenticity and ownership.
This opens up an array of possibilities, such as facilitating the secure transfer of research data, protecting intellectual property rights, and enabling personalized therapies based on a patient’s unique iPS cell profile.
